Stroke Devices: Innovation Drives Growth
This article was originally published in Start Up
Executive Summary
Innovation is driving double-digit growth in the neurointerventional device market as an increasing number of medical device manufacturers develop newer, more effective devices for treating acute ischemic stroke. As new, stent-like retrieval systems and other next-generation neurothrombectomy devices hit the US market in the next few years, competition in this sector will also heat up as manufacturers try to differentiate their devices and jockey for a piece of the market, which is projected to reach almost $70 million by 2015.
You may also be interested in...
Covidien Plans April U.S. Launch Of Solitaire For Ischemic Strokes
Clot removal device gains 510(k) clearance earlier than expected, will compete with Stryker’s Merci clot retrieval system.
The Neurovascular Market Tilts Toward A Tipping Point
Acute ischemic stroke used to be a device category that promised a slow but certain death for start-ups. But there's lots of life in the market, as evidenced by a recent wave of consolidation. Meanwhile, hemorrhagic stroke companies have been perfecting the treatment of cerebral aneurysms.
Neurointerventional Market Shows Strong Growth Potential
The neurointerventional device market is one of the most dynamic areas in the field of neurology. Over the next four years, US neurointerventional procedures are expected to grow at a rate of nearly 18% compounded annually, reaching more than 197,000 procedures by 2015. The market information in this article was compiled from Medtech Insight’s new report "US Markets for Neurosurgical and Neurointerventional Surgical Products," #A590, published March 2011.